“celgene” Archives

in
Entry Author Date Location
Celgene Pays Anokion $45M for Autoimmune Research, Option to Buy 01/09/17 New York
Versant Closes on $400M Fund, Eyes More Biotech Deals in Europe 01/03/17 San Francisco
First Trial Underway, Jounce Preps IPO To Fund Immuno-Oncology Work 01/03/17 Boston
Bio Roundup: Crazy ’16, Trials of ’17, Senate on Drugs & More 12/23/16 National
14 for ’17: Key Clinical Data To Watch For Next Year (Part 2) 12/22/16 National
After FDA Hold, Agios Quickly Scraps One Anemia Drug, Turns to Another 12/15/16 Boston
BlueRock Raises $225M To Repair Heart Damage With Stem Cells 12/12/16 Boston
Bio Roundup: Fast “Cures,” Trump In Time, CRISPR In Court & More 12/09/16 National
TCR2 Therapeutics Unveils New Cancer Therapy Approach and $44.5M Round 12/08/16 Boston
At Late-Night ASH Talk, Juno Execs Look Beyond Stalled “Rocket” Trial 12/06/16 Seattle
ASH Roundup: CAR-T Shuffle, Hemophilia Updates, Checkpoint Progress & More 12/06/16 National
Acetylon Crafts New Buyout Deal With Celgene, Spins Out Startup Regenacy 12/02/16 Boston
Bio Roundup: CAR-T Ups & Downs, Lilly’s Failure, Myeloma & More 12/02/16 National
Celgene Invests More in GNS Healthcare For Machine Learning Software 11/29/16 Boston
Bio Roundup: Trump’s Rx Silence, PCSK9 News, Amgen’s Migraines & More 11/18/16 National
Led by Former Lilly Exec, Apexian Out to Tackle Pancreatic Cancer 11/16/16 Indiana
Bio Roundup: Trump’s Triumph, Election Fallout, CRISPR Arguments & More 11/11/16 National
Bio Roundup: Jenkins Gets Mad, Bernie Gets His Pen, CRISPR IPO & J-Lo 10/21/16 National
BlackThorn Emerges With $40M, New Weapons Against Neuro Disorders 10/20/16 San Francisco
Ex-Celgene Dealmaker Tom Daniel Charts a New Course Advising Biotechs 10/17/16 New York
Bio Roundup: CAR-T & Migraine Races, Intra-Cellular, Rockefeller & More 09/30/16 National
Aligned With Roche, SQZ Bio Gets $16M to Push Cell Therapies to Clinic 09/30/16 Boston
Biotech Roundup: CRISPR’s 3rd IPO, Gender Diversity, Buyouts & More 09/16/16 National
Celgene Touts Data From Early Study of Oral GI Drug 09/12/16 Boston
Seeking to Join Editas, Intellia, CRISPR Tx Makes Long Awaited IPO Push 09/12/16 Boston
Celgene Plots Speedy FDA Filing for Agios Blood Cancer Drug 09/07/16 Boston
Pfizer Shells Out $14B to Win Medivation Sweepstakes 08/22/16 San Francisco
With New Name and $86M, Tioma To Explore Anti-CD47 Cancer Therapy 08/16/16 San Francisco
Bio Roundup: Precision Med and Google, Heron, Lilly, Sarepta & More 08/12/16 National
MIT’s Jacks Leans on Disney Family, Not VCs, to Hatch New Startup 08/11/16 Boston
Page 1 of 13 next page »